Prospective Evaluation of Lymphoedema Among Patients With Gynaecological Cancer (NCT00604994) | Clinical Trial Compass
CompletedNot Applicable
Prospective Evaluation of Lymphoedema Among Patients With Gynaecological Cancer
Australia761 participantsStarted 2008-06
Plain-language summary
This project will conduct a prospective, longitudinal, observational cohort study to assess the onset and incidence of lymphoedema, as well as investigate factors associated with its development among women newly diagnosed with gynaecological cancers in 2008 to 2011.
Who can participate
Age range
18 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients scheduled for surgery of benign or malignant gynaecological diseases as determined jointly by the surgeon and the patient.
* Non-pregnant female patients.
* Over 18 years of age at time of surgery.
* Patients who understand the conditions of the study and are willing to participate for the length of the prescribed term of follow-up.
* Patients who are capable of, and have given, informed consent to their participation in the study.
Exclusion Criteria:
* Patients with a pacemaker.
* Allergies against adhesive electrodes and extensive internal metal plates are ineligible for BIS measurement.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Time of onset of lymphoedema after gynaecological cancer treatment.
Timeframe: 2 years
2
Incidence of lymphoedema after gynaecological cancer treatment.
Timeframe: 2 years
3
Point prevalence of lymphoedema after gynaecological cancer treatment.
Timeframe: 2 years
4
Severity of lymphoedema after gynaecological cancer treatment.
Timeframe: 2 years
Trial details
NCT IDNCT00604994
SponsorQueensland Centre for Gynaecological Cancer